+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Hematology Market - Growth, Trends, and Forecast (2020-2025)

  • ID: 4591343
  • Report
  • May 2020
  • Region: Global
  • 116 pages
  • Mordor Intelligence
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now


  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Dolomite Centre
  • F.Hoffmann-La Roche AG
  • MORE
The growth of the hematology market is attributed to the increasing incidences of blood disorders and other diseases, rapid technological advances in hematology, and the emergence of high throughput hematology analyzers.

Blood disorders have become a global health issue with different causes, and are associated with high mortality. Blood disorders, such as anemia, blood cancer, hemorrhagic conditions, and blood infections, affect millions of people each year across all age groups. According to WHO, hemoglobin disorders are potentially affecting 75% of births, globally, and sickle cell trait affects an estimated one in 12 African Americans. Over 70% of all sickle-cell affected births occur in Africa. As per the World Health Organization, the prevalence of anemia in children is 47.4% and 12.7% in men, and it is increasing rapidly all over the world. According to the National Institute of Health (NIH), anemia affects 29% of women with reproductive age and 38% of pregnant women, worldwide.

Hemophilia, a genetic bleeding disorder that prevents the blood from clotting normally, affects one in 5,000 male births. About 400 babies are born with hemophilia, each year, in the United States. The global incidence of hemophilia is observed in more than 400,000 people. The most common blood disorder, venous thromboembolism, affects at least 1 million people in the United States and it is a major cause of death in adults. Leukemia, lymphoma, myeloma, and myelodysplastic syndromes are types of highly prevalent cancers. Approximately every 3 minutes, one person in the United States is diagnosed with a type of blood cancer. The need to address the rising burden of blood disorders is increasing. Early diagnosis and treatment are the best ways to protect the quality of life for a patient with blood cell disorder.

Key Market Trends

The Patient Self-testing Segment, under End User is Expected to Grow at the Fastest Rate, during the Forecast Period

The clinical testing institutes segment held a maximum share in 2019, due to the increasing awareness for hematology testing, shift from manual testing to automated testing, and competitive benefits offered by these providers, as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management for sample collection).

The patient self-testing segment is projected to show significant growth during the forecast period, owing to the growing cases of hematology disorders, such as anemia and iron deficiency, as well as infectious diseases.

The North American Region Holds the Largest Market Share of the Hematology Market, and is Expected to Follow the Same Trend over the Forecast Period

Currently, North America is the largest market for hematology analyzers. This market trend can be attributed to the increasing incidence of blood disorders. The increasing cases of blood-related disorders, such as anemia, blood cancer, etc., may lead to the growth of the hematology market.

Asia Pacific is expected to register the fastest CAGR. The rise in per capita income leading to increased adoption of diagnostic and therapy products coupled with government initiatives to improve healthcare infrastructure are expected to fuel the regional market growth.

Competitive Landscape

The global market is highly competitive. Some key industry participants include Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc., Danaher Corporation and F. Hoffmann-La Roche Ltd . The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market position. For instance, in November 2017, Sysmex acquired CLIA Waiver, for the New Automated Hematology Analyzer.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 5


  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Dolomite Centre
  • F.Hoffmann-La Roche AG
  • MORE
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Blood Disorders and Other Diseases
4.2.2 Rapid Technological Advances in Hematology
4.2.3 Emergence of High Throughput Hematology Analyzers
4.3 Market Restraints
4.3.1 High Cost of the Instruments
4.3.2 Low Adoption of Hematology Analyzers in Emerging Economies
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Hematology Analyzers
5.1.2 Flow Cytometers
5.1.3 Coagulation Analyzers
5.1.4 Slide Stainers
5.1.5 Centrifuges
5.1.6 Hemoglobinometers
5.1.7 Other Products
5.2 By Reagent
5.2.1 Coagulation Reagents
5.2.2 Flow Cytometery Reagents
5.2.3 Immuno-hematology Reagents
5.2.4 Other Reagents
5.3 By Application
5.3.1 Drug Testing
5.3.2 Auto Immune Disease
5.3.3 Cancer
5.3.4 Diabetes Mellitus
5.3.5 Infectious Disease
5.3.6 Other Applications
5.4 By End User
5.4.1 Hospitals
5.4.2 Clinical Testing Institutes
5.4.3 Patient Self-testing
5.4.4 Other End Users
5.5 Geography
5.5.1 North America United States Canada Mexico
5.5.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.5.4 Middle-East & Africa GCC South Africa Rest of Middle-East & Africa
5.5.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Agilent Technologies Inc.
6.1.3 Bio-Rad Laboratories Inc.
6.1.4 Danaher Corporation
6.1.5 Dolomite Centre
6.1.6 F.Hoffmann-La Roche AG
6.1.7 Novo Nordisk AS
6.1.8 Fluidigm Corporation
6.1.9 Micronit Microfluidics BV
6.1.10 PerkinElmer Inc.
6.1.11 Thermo Fisher Scientific Inc.
6.1.12 uFluidix

Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Dolomite Centre
  • F.Hoffmann-La Roche AG
  • Novo Nordisk AS
  • Fluidigm Corporation
  • Micronit Microfluidics BV
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • uFluidix
Note: Product cover images may vary from those shown
5 of 5